Latest Travelzoo Inc (TZOO) Headlines Fly.com Reveals

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Travelzoo Inc (TZOO) Headlines

Fly.com Reveals Best and Worst Spring Break Airfare Deals
PR Newswire - Thu Feb 20, 9:12AM CST
As college students and families across America prepare to go on spring break, new research from Fly.com(TM) has identified the best and worst destinations for budget-conscious travelers still looking to purchase flights for the mid-term getaway.

Last-Minute Valentine's Day Deals: 8 Getaways Still Available
PR Newswire - Tue Feb 11, 4:50PM CST
Travelzoo Inc. (NASDAQ: TZOO), a global Internet media company, revealed more than one-third (37%) of Americans would love a romantic getaway to celebrate Valentine's Day. With this year's holiday coinciding with Presidents Day weekend, lovebirds are competing with families for airline seats and hotel rooms over this popular travel holiday, driving up the cost of a romantic getaway.

Commit To Buy TravelZoo At $17.50, Earn 8.8% Annualized Using Options
StockOptionsChannel.com - Fri Feb 07, 10:35AM CST
Investors eyeing a purchase of TravelZoo shares, but tentative about paying the going market price of $22.00/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in...

What Travelers Really Think About Airline Fees
PR Newswire - Thu Jan 30, 9:24AM CST
Ancillary fees are big business for airlines. A recent industry report suggests that North American carriers collected $17.2 billion in ancillary revenue during 2013. But what are these fees really costing airlines in terms of customer satisfaction? As airlines gear up to add yet more fees in 2014, new research from Fly.com reveals a discrepancy between the services that fliers are willing to pay for and the services and amenities currently being offered to them.

Travelzoo Faces a Long Road Ahead
Michael Lewis, The Motley Fool - Motley Fool - Wed Jan 29, 2:00PM CST
Is Travelzoo a better bang for you buck when it comes to web-based travel agents? The company is a fraction of the size of peers such as Priceline or the recently bought-out Kayak Software , and it holds far more attractive valuation metrics....

Maverix Lands $100,000 Order From University of Missouri For 99 Lives Cat Whole Genome Sequencing Initiative
PR Newswire - Wed Jan 29, 8:30AM CST
Maverix Biomics, Inc. is pleased to announce that it has received a $100,000 order from the University of Missouri for the analysis of feline genomes as part of the 99 Lives Cat Whole Genome Sequencing Initiative, a joint project between the University of Missouri, the University of California, Davis, and industrial partners. In addition, Maverix will be hosting the 99 Lives Cat Whole Genome Sequencing Initiative genome and analysis data as a free, publicly-accessible "Community of Discovery."

Travelzoo: Does an Assessment of Growth and Valuation Suggest a Buy?
Brian Nichols, The Motley Fool - Motley Fool - Thu Jan 23, 9:00PM CST
Travelzoo is a considerably smaller online travel company relative to its peers Priceline.com and Expedia . While many remain optimistic of the company's future, a simple comparison highlights problems that investors should consider before...

Travelzoo Reports Fourth Quarter 2013 Results and Announces Share Repurchase Program
Business Wire - Thu Jan 23, 7:00AM CST
Travelzoo Inc. (NASDAQ:TZOO):

Travelzoo Q4 2013 Earnings Conference Call Thursday, January 23 at 11:00 AM ET
Business Wire - Fri Jan 17, 4:46PM CST
Travelzoo Inc. (NASDAQ: TZOO):

Travelzoo Asia Pacific Survey predicts increase in 2014 Asian travel budget
M2 Airline Industry Information - Thu Jan 16, 8:17AM CST
16 January 2014

19.7% Return Seen to Date on SmarTrend Travelzoo Call (TZOO)
Comtex SmarTrend(R) - Wed Jan 15, 4:48PM CST
SmarTrend identified a Downtrend for Travelzoo (NASDAQ:TZOO) on August 28th, 2013 at $27.94. In approximately 5 months, Travelzoo has returned 19.67% as of today's recent price of $22.44.

Travelzoo Asia Pacific Survey Forecasts 17% Increase In 2014 Asian Travel Budget
PR Newswire - Wed Jan 15, 8:00AM CST
Travelzoo Asia Pacific, a licensee of global Internet media company Travelzoo Inc. (NASDAQ: TZOO), today announced that its annual subscriber survey findings showed that the Asian travel appetite in 2014 will get stronger, with a forecasted increase of 17 percent in travel budgets over last year's. The results also highlighted transformations in the vacation spending patterns of Mainland Chinese travelers, with the majority willing to spend more for upgrading their holiday experiences and high-end accommodations.

Executive Appointments, Conference Presentation Schedules, and Small Business Summit - Research Report on Qihoo 360, Trulia, Travelzoo, j2 Global, and Web.com
PR Newswire - Mon Jan 13, 7:00AM CST
Today, Analysts' Corner announced new research reports highlighting Qihoo 360 Technology Co., Ltd. (NYSE: QIHU), Trulia, Inc. (NYSE: TRLA), Travelzoo Inc. (NASDAQ: TZOO), j2 Global, Inc. (NASDAQ: JCOM), and Web.com Group, Inc. (NASDAQ: WWWW). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Travelzoo names Eddie Garcia as SVP of product development in its Search business segment
M2 - Thu Jan 09, 7:01AM CST
Travelzoo Inc (NASDAQ:TZOO), an Internet media company, on Wednesday named Eddie Garcia as senior vice president (SVP) of Product Development, strengthening its leadership in the Search segment.

Nasdaq stocks posting largest volume increases
AP - Wed Jan 08, 5:15PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:

Travelzoo Inc. Announces Developments in its Search Business Segment
Business Wire - Wed Jan 08, 2:00PM CST
Travelzoo Inc. (NASDAQ:TZOO), a global Internet media company, today announced the appointment of Mr. Eddie Garcia as Senior Vice President of Product Development, strengthening the company's leadership in Search. The appointment comes after a year of declines in Travelzoo's Search revenues, which accelerated further in the fourth quarter ending December 31, 2013.

Travelzoo Down 17.3% Since SmarTrend Downtrend Call (TZOO)
Comtex SmarTrend(R) - Wed Jan 08, 11:04AM CST
SmarTrend identified a Downtrend for Travelzoo (NASDAQ:TZOO) on August 28th, 2013 at $27.94. In approximately 4 months, Travelzoo has returned 17.31% as of today's recent price of $23.10.

Shares of TZOO Down 21.7% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Tue Dec 31, 11:15AM CST
SmarTrend identified a Downtrend for Travelzoo (NASDAQ:TZOO) on August 28th, 2013 at $27.94. In approximately 4 months, Travelzoo has returned 21.69% as of today's recent price of $21.88.

23.9% Return Seen to Date on SmarTrend Travelzoo Call (TZOO)
Comtex SmarTrend(R) - Tue Dec 24, 9:51AM CST
SmarTrend identified a Downtrend for Travelzoo (NASDAQ:TZOO) on August 28th, 2013 at $27.94. In approximately 4 months, Travelzoo has returned 23.86% as of today's recent price of $21.27.

Proof: Corporate Culture Matters in Investing
Brian Stoffel, The Motley Fool - Motley Fool - Wed Dec 18, 5:35PM CST
Lots of investors think the key to finding wealth-creating returns is to meticulously study a company's financial statements. That strategy may work, but if you're a beginning investor who isn't sure where to start, know that this is far from the ...

TravelZoo Inc. (TZOO) Stock Research Links

TZOO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 2

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Insightful Findings on gMG Treatments by UCB at AANEM 2024

Updated Category News Views 127

UCB Highlights Innovations in Generalized Myasthenia Gravis Treatments at AANEM 2024 UCB, a prominent global biopharmaceutical company, is gearing up to present its latest findings in the management of generalized myasthenia gravis (gMG) at the upcoming American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) meeting. The event, which will also feature...

Continue Reading
Lysander Funds Shares New Distributions Estimates for ETFs

Updated Category News Views 131

Lysander Funds Shares New Distributions Estimates Lysander Funds Limited recently made an announcement about the anticipated cash distributions for December 2024 for their exchange-traded funds (ETFs). The focus is on three notable ETFs: Lysander-Slater Preferred Share ActivETF, Lysander-Canso Corporate Treasury ActivETF, and Lysander-Canso Floating Rate ActivETF. Each of...

Continue Reading
Empowering Girls: Pace Center's Initiatives for Growth

Updated Category News Views 350

Introduction to the Capital Campaign Pace Center for Girls Hillsborough is excited to announce its capital campaign aimed at expanding its capacity and enhancing the support provided to girls in the community. Through dedicated efforts such as education, counseling, and training, this campaign signifies a crucial step towards bettering the future for girls in Hillsborough...

Continue Reading
Bank of America Sees Growth in Loans, Deposits Amid Profit Rise

Updated Category News Views 284

Bank of America Reports Increased Earnings and Efficiency Bank of America Corp (NASDAQ: BAC) has announced strong financial results for the second quarter, showcasing impressive growth in loans, deposits, and overall profitability. The bank reported a net income of $7.1 billion, a slight increase from $6.9 billion the previous year, along with an earnings per share (EPS)...

Continue Reading
Investigating Manitex International: A Closer Look at MNTX

Updated Category News Views 72

Examining Fair Treatment for Manitex International Shareholders Ademi LLP has launched an investigation into Manitex International, Inc. (NASDAQ: MNTX) due to concerns about possible breaches of fiduciary duty related to its recent transaction with Tadano. This investigation raises important questions about whether shareholders are being treated fairly in the financial...

Continue Reading